Related Experiment Videos

Eikenella corrodens in human mouth flora

G M Rayan1, J L Putnam, S L Cahill

  • 1Orthopaedic Surgery Department, University of Oklahoma Health Sciences Center, Oklahoma City.

Insights

Eikenella corrodens, a bacterium found in the human mouth, was identified in 2.6% of individuals studied. Second- or third-generation cephalosporins demonstrated 100% effectiveness against isolates, suggesting their use for human bite injuries.

Area of Science:

  • Oral microbiology
  • Infectious diseases
  • Antimicrobial susceptibility testing

Background:

  • Eikenella corrodens is a component of the normal human oral flora.
  • Human bite injuries can lead to infections, often polymicrobial.
  • Understanding the prevalence and antimicrobial susceptibility of E. corrodens is crucial for effective treatment.

Purpose of the Study:

  • To determine the incidence of Eikenella corrodens in the human oral cavity.
  • To assess the in vitro antimicrobial susceptibility of E. corrodens isolates.
  • To provide recommendations for empiric antibiotic therapy for human bite injuries.

Main Methods:

  • Culture analysis of saliva and tooth scrapings from 229 individuals.
  • Disc-agar diffusion method to test 11 E. corrodens isolates against 33 antimicrobials.
  • Statistical analysis of incidence and susceptibility data.

Main Results:

  • Eikenella corrodens was detected in 2.6% of the 229 individuals.
  • The incidence was significantly higher in tooth scrapings (8.2%) compared to saliva (0.6%).
  • 100% susceptibility was observed for second- and third-generation cephalosporins, and 82% for penicillin, cephalothin, and cefoperazone.

Conclusions:

  • Eikenella corrodens has a low incidence in human saliva but is more prevalent on teeth.
  • Second- and third-generation cephalosporins are highly effective against E. corrodens isolates.
  • Empiric therapy with second- or third-generation cephalosporins is recommended for human bite injuries involving E. corrodens.

Related Concept Videos